1. Home
  2. AVDL vs JBSS Comparison

AVDL vs JBSS Comparison

Compare AVDL & JBSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVDL
  • JBSS
  • Stock Information
  • Founded
  • AVDL 2015
  • JBSS 1959
  • Country
  • AVDL Ireland
  • JBSS United States
  • Employees
  • AVDL N/A
  • JBSS N/A
  • Industry
  • AVDL Biotechnology: Pharmaceutical Preparations
  • JBSS Specialty Foods
  • Sector
  • AVDL Health Care
  • JBSS Consumer Staples
  • Exchange
  • AVDL Nasdaq
  • JBSS Nasdaq
  • Market Cap
  • AVDL 784.6M
  • JBSS 795.1M
  • IPO Year
  • AVDL 1996
  • JBSS 1991
  • Fundamental
  • Price
  • AVDL $8.03
  • JBSS $68.45
  • Analyst Decision
  • AVDL Strong Buy
  • JBSS
  • Analyst Count
  • AVDL 7
  • JBSS 0
  • Target Price
  • AVDL $18.86
  • JBSS N/A
  • AVG Volume (30 Days)
  • AVDL 1.1M
  • JBSS 68.5K
  • Earning Date
  • AVDL 05-07-2025
  • JBSS 04-30-2025
  • Dividend Yield
  • AVDL N/A
  • JBSS 4.54%
  • EPS Growth
  • AVDL N/A
  • JBSS N/A
  • EPS
  • AVDL N/A
  • JBSS 4.16
  • Revenue
  • AVDL $169,117,000.00
  • JBSS $1,118,719,000.00
  • Revenue This Year
  • AVDL $50.53
  • JBSS N/A
  • Revenue Next Year
  • AVDL $32.33
  • JBSS N/A
  • P/E Ratio
  • AVDL N/A
  • JBSS $16.45
  • Revenue Growth
  • AVDL 504.79
  • JBSS 12.09
  • 52 Week Low
  • AVDL $6.38
  • JBSS $65.29
  • 52 Week High
  • AVDL $19.09
  • JBSS $105.63
  • Technical
  • Relative Strength Index (RSI)
  • AVDL 54.47
  • JBSS 45.69
  • Support Level
  • AVDL $6.38
  • JBSS $66.61
  • Resistance Level
  • AVDL $8.22
  • JBSS $69.44
  • Average True Range (ATR)
  • AVDL 0.48
  • JBSS 2.28
  • MACD
  • AVDL 0.11
  • JBSS 0.12
  • Stochastic Oscillator
  • AVDL 89.67
  • JBSS 48.10

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

About JBSS John B. Sanfilippo & Son Inc.

John B Sanfilippo & Son Inc is one of the processors and distributors of peanuts, pecans, cashews, walnuts, almonds, and other nuts in the United States. These nuts are sold under a variety of private brands and under the Fisher, Orchard Valley Harvest, and Sunshine Country brand names. It also market and distribute, and in the majority of cases, manufacture or process, a diverse product line of food and snack products, including peanut butter, almond butter, cashew butter, candy and confections, snacks and trail mixes, snack bites, sunflower kernels, dried fruit, corn snacks, sesame sticks and other sesame snack products under private brands and brand names.

Share on Social Networks: